Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALStandard

IPRATROPIUM BROMIDE

IPRATROPIUM BROMIDE

Standard Dose
0.021MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 219222 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IPRATROPIUM BROMIDE Form and strength SPRAY, METERED;NASAL - 0.021MG/SPRAY Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2025-01-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 219222 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IPRATROPIUM BROMIDE Form and strength SPRAY, METERED;NASAL - 0.021MG/SPRAY Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2025-01-14 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.